Skip to main content

Advertisement

Table 2 Characteristics and prevalence of comorbid conditions in white females

From: Sex-specific responses to mineralocorticoid receptor antagonism in hypertensive African American males and females

Variable NTN (n = 182) HTN (n = 490) HTN + Spiro (n = 12)
Age (year) 51 ± 9 61 ± 9* 58 ± 11*
BMI (kg/m2) 29 ± 7 32 ± 7* 34 ± 5*
SBP (mmHg) 120 ± 13 136 ± 20* 132 ± 24*
HTN medications 0 1.6 ± 0.9* 1.7 ± 0.8*
HTN duration (year) 0 14 ± 12* 22 ± 14*
eGFR (ml/min) 100 ± 8 90 ± 13* 90 ± 11*
Total urinary protein (mg) 2 ± 2 2 ± 4 2 ± 1
Uncontrolled HTN (%) 0 42* 25*
CHD (%) 1 11* 25*
MI (%) 0 5* 0
Stroke (%) 1 3* 8*
Diabetes (%) 3 13* 42*#
  1. NTN normotension, HTN hypertension, HTN + Spiro hypertension with spironolactone treatment, BMI body mass index, HTN hypertension, eGFR estimate glomerular filtration rate, LV left ventricle, CHD coronary heart disease, MI myocardial infarction. *p < 0.05 vs. NTN, #p < 0.05 vs. HTN